Women’s health pharma company Organon has launched a new website, Fertility Journey, with the goal to inform and empower people with resources and information needed to navigate the process of fertility care. The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.
“Infertility is a significant public health issue in the U.S. While the issue affects both men and women, the burden of treatment typically falls on women, with 7.3 million women reporting the use of infertility services in the U.S. from 2006-2010,” said Dr. Barbara Stegmann, clinical lead of women’s health for Organon. “We want to provide support to anyone looking to start a family and for those accompanying them. I am proud to work at Organon where we are truly devoted to understanding the journey.”
Organon’s new Fertility Journey website offers:
- Insights to understand what can cause infertility and the many factors that can contribute to it in both men and women
- What to expect from the first fertility consultation, how to best prepare for that appointment – including questions for consideration
- A description of clinical tests or evaluations that may be conducted to help identify an individualized fertility treatment plan and ways to navigate the associated cost and coverage options
- Help prepare for the emotional and physical challenges that may arise
“At Organon, we are fully invested in listening to her needs and are dedicated to championing care by creating options built around these needs,” said Mike Pohleven, U.S. Fertility Lead at Organon. “This launch marks a key milestone in our mission to elevate fertility education and provide resources to help people along their fertility journey, and reiterates our commitment to being a source of information for women and their care team.”
The website launch is in tandem with the 77th American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo in Baltimore, MD, where Organon will be participating in fertility conversations and discussing their current fertility products.
Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.
